Barclays Remains a Buy on American Healthcare REIT, Inc. (AHR)

In a report released today, Anthony Powell from Barclays maintained a Buy rating on American Healthcare REIT, Inc. (AHR – Research Report), with a price target of $18.00. The company’s shares closed last Thursday at $14.75.

According to TipRanks, Powell is an analyst with an average return of -3.7% and a 46.43% success rate. Powell covers the Real Estate sector, focusing on stocks such as Cousins Properties, Mid-America Apartment, and Sun Communities.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for American Healthcare REIT, Inc. with a $15.78 average price target, implying a 6.98% upside from current levels. In a report released on March 25, Bank of America Securities also maintained a Buy rating on the stock with a $15.00 price target.

The company has a one-year high of $14.90 and a one-year low of $12.41. Currently, American Healthcare REIT, Inc. has an average volume of 1.24M.

Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AHR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

American Healthcare REIT, Inc. (AHR) Company Description:

American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company’s assets having built and nurtured the company’s international portfolio since its original property acquisition in 2014.